Nothing Special   »   [go: up one dir, main page]

DE69920747D1 - Methode zur herstellung von rekombinanten zellen - Google Patents

Methode zur herstellung von rekombinanten zellen

Info

Publication number
DE69920747D1
DE69920747D1 DE69920747T DE69920747T DE69920747D1 DE 69920747 D1 DE69920747 D1 DE 69920747D1 DE 69920747 T DE69920747 T DE 69920747T DE 69920747 T DE69920747 T DE 69920747T DE 69920747 D1 DE69920747 D1 DE 69920747D1
Authority
DE
Germany
Prior art keywords
recombinant
cell lines
recombinant cells
production
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920747T
Other languages
English (en)
Other versions
DE69920747T2 (de
Inventor
Jorge L Acevedo
R Rhode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunol Molecular Corp
Original Assignee
Sunol Molecular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunol Molecular Corp filed Critical Sunol Molecular Corp
Application granted granted Critical
Publication of DE69920747D1 publication Critical patent/DE69920747D1/de
Publication of DE69920747T2 publication Critical patent/DE69920747T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69920747T 1998-12-03 1999-11-30 Methode zur herstellung von rekombinanten zellen Expired - Lifetime DE69920747T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/204,979 US6156514A (en) 1998-12-03 1998-12-03 Methods for making recombinant cells
US204979 1998-12-03
PCT/US1999/028255 WO2000032821A1 (en) 1998-12-03 1999-11-30 Methods for making recombinant cells

Publications (2)

Publication Number Publication Date
DE69920747D1 true DE69920747D1 (de) 2004-11-04
DE69920747T2 DE69920747T2 (de) 2005-10-06

Family

ID=22760275

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920747T Expired - Lifetime DE69920747T2 (de) 1998-12-03 1999-11-30 Methode zur herstellung von rekombinanten zellen

Country Status (12)

Country Link
US (2) US6156514A (de)
EP (1) EP1137808B1 (de)
JP (1) JP2002531103A (de)
CN (1) CN1202261C (de)
AT (1) ATE278024T1 (de)
AU (1) AU770119B2 (de)
CA (1) CA2353575A1 (de)
DE (1) DE69920747T2 (de)
DK (1) DK1137808T3 (de)
ES (1) ES2230908T3 (de)
TW (1) TWI221483B (de)
WO (1) WO2000032821A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
AU2001271614B2 (en) * 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
WO2009003492A1 (en) * 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
WO2003064659A1 (en) * 2002-01-11 2003-08-07 Genetica, Inc. Methods and compositions for optimizing recombinant expression
WO2003096966A2 (en) * 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells
KR20050095605A (ko) * 2003-01-09 2005-09-29 제넨테크, 인크. 폴리펩티드의 정제
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
US20090061478A1 (en) * 2006-01-30 2009-03-05 Lene Have Poulsen High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
EP2361930A3 (de) 2007-03-26 2011-10-26 Dako Denmark A/S Multimere von peptide-mhc komplexen und deren verwendung in borrelia infektionskrankheiten
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
WO2017007994A1 (en) 2015-07-08 2017-01-12 American Gene Technologies International Inc. Hiv pre-immunization and immunotherapy
AU2017207906B2 (en) 2016-01-15 2021-03-11 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
WO2017139065A1 (en) 2016-02-08 2017-08-17 American Gene Technologies International Inc. Hiv vaccination and immunotherapy
EP3426777B1 (de) 2016-03-09 2022-02-16 American Gene Technologies International Inc. Kombinationsvektoren und verfahren zur behandlung von krebs
WO2017213697A1 (en) * 2016-06-08 2017-12-14 American Gene Technologies International Inc. Non-integrating viral delivery system and methods related thereto
JP6971492B2 (ja) 2016-07-08 2021-11-24 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド Ｈｉｖ予備免疫化および免疫療法
US11583562B2 (en) 2016-07-21 2023-02-21 American Gene Technologies International Inc. Viral vectors for treating Parkinson's disease
EP3607072A4 (de) 2017-04-03 2021-01-06 American Gene Technologies International Inc. Zusammensetzungen und verfahren zur behandlung von phenylketonurie

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167442D1 (en) * 1980-07-07 1985-01-10 Nat Res Dev Improvements in or relating to cell lines
US4766067A (en) * 1985-05-31 1988-08-23 President And Fellows Of Harvard College Gene amplification
IL80511A0 (en) * 1985-11-05 1987-02-27 Genetics Inst Multiply amplifiable vectors for high level expression of exogenous dna
JP2637532B2 (ja) * 1987-02-27 1997-08-06 ギスト ブロカデス ナームローゼ フェンノートチャップ 原核微生物の染色体ｄｎａにおける安定した遺伝子増幅
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
WO1989010959A1 (en) * 1988-05-06 1989-11-16 Codon Supertransformants for high expression rates in eukaryotic cells
WO1990006363A1 (en) * 1988-12-08 1990-06-14 Damon Biotech, Inc. Expression induction method employing mutant dhfr gene
ES2214474T3 (es) * 1991-05-31 2004-09-16 Genentech, Inc. Aumento de la expresion mediante orientacion genica en secuencias endogenas de tipo retrovirus.
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
AU7568094A (en) * 1993-08-12 1995-03-14 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5658763A (en) * 1993-10-25 1997-08-19 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA
WO1995017513A1 (en) * 1993-12-23 1995-06-29 Novo Nordisk A/S Retransformation of filamentous fungi
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods

Also Published As

Publication number Publication date
US6156514A (en) 2000-12-05
WO2000032821A1 (en) 2000-06-08
CN1328605A (zh) 2001-12-26
DK1137808T3 (da) 2005-01-31
DE69920747T2 (de) 2005-10-06
EP1137808B1 (de) 2004-09-29
US6306605B1 (en) 2001-10-23
CA2353575A1 (en) 2000-06-08
AU1835600A (en) 2000-06-19
TWI221483B (en) 2004-10-01
JP2002531103A (ja) 2002-09-24
ES2230908T3 (es) 2005-05-01
EP1137808A4 (de) 2002-10-02
EP1137808A1 (de) 2001-10-04
CN1202261C (zh) 2005-05-18
AU770119B2 (en) 2004-02-12
ATE278024T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
DE69920747D1 (de) Methode zur herstellung von rekombinanten zellen
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
WO2002029083A3 (en) Industrial-scale serum-free production of recombinant proteins in mammalian cells
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
DE3851289D1 (de) Verfahren zur Züchtung rekombinanter Zellen.
ATE213271T1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte- fermentation
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
DE60232773D1 (de) Verfahren zur Herstellung von Membran-Elektrode-Anordnungen für Brennstoffzellen
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
DE69417011D1 (de) Verfahren zur herstellung von kathoden komponenten und zu ihrer verwendung in elektrochemischen zellen
ATE457355T1 (de) Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute
ATE111956T1 (de) Co-expression in eukaryontischen zellen.
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
DE69939548D1 (de) Verfahren zur herstellung von faktor vii
HUP0303843A2 (hu) CLyA-hemolizin alkalmazása proteinek exkretáltatására
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
DE69604550D1 (de) Verfahren zur Herstellung von Lithiumionzelle mit deaktivierter Kohlenstoffanode
ATE362544T1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
DE69425809D1 (de) Methoden zur Herstellung von Protein C
WO2002008417A1 (fr) Procede de production d'une proteine de recombinaison
ATE273391T1 (de) Neurotrophischer faktor nnt-1
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition